Jolley, SE, Bunnell, AE, Hough, CL. ICU-acquired weakness. Chest 2016; 150: 1129.Google Scholar

Kress, JP, Hall, JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med 2014; 370: 1626.Google Scholar

Vanhorebeek, I, Latronico, N, Van den Berghe G. ICU-acquired weakness. Intens Care Med 2020; 46: 637.CrossRefGoogle ScholarPubMed

Agusti, C, Xaubet, A, Roca, J, et al. Interstitial pulmonary fibrosis with and without associated collagen vascular disease. Thorax 1992; 47: 1035.CrossRefGoogle ScholarPubMed

Behr, J, Kolb, M, Cox, G. Treating IPF – all or nothing? A PRO-CON debate. Respirology 2009; 14: 1072.Google ScholarPubMed

Canestaro, WJ, Forrester, SH, Raghu, G, et al. Drug treatment of idiopathic pulmonary fibrosis: systematic review and network meta-analysis. Chest 2016; 149: 756.Google Scholar

Carrington, CB, Gaensler, EA, Coutu, RE, et al. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298: 801.Google Scholar

Cherniack, RM, Colby, TV, Flint, A, et al. Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151: 1180.Google ScholarPubMed

Crystal, RG, Bitterman, PB, Rennard, SI, et al. Interstitial lung diseases of unknown cause. N Engl J Med 1984; 310: 154 & 235.CrossRefGoogle ScholarPubMed

Flaherty, KR, Toews, GB, Lynch, JP, et al. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med 2001; 110: 278.Google Scholar

Fumeaux, T, Rothmeier, C, Jolliet, P. Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis. Intens Care Med 2001; 27: 1868.CrossRefGoogle ScholarPubMed

Gross, TJ, Hunninghake, GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345: 517.CrossRefGoogle ScholarPubMed

Homma, Y, Ohtsuka, Y, Tanimura, K, et al. Can interstitial pneumonia as the sole presentation of collagen vascular disease be differentiated from idiopathic interstitial pneumonia. Respiration 1995; 62: 248.Google Scholar

Hubbard, R, Lewis, S, Richards, K, et al. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996; 347: 284.CrossRefGoogle ScholarPubMed

International Consensus Statement. Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 2000; 161: 646.CrossRefGoogle Scholar

Jo, HE, Troy, LK, Keir, G, et al. Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: a position statement from the Thoracic Soociety of Australia and New Zealand and the Lung Foundation Australia. Respirology 2017; 22: 1436.Google Scholar

Johnston, IDA, Prescott, RJ, Chalmers, JC, et al. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 1997; 52: 38.CrossRefGoogle ScholarPubMed

Kamp, DW. Idiopathic pulmonary fibrosis: the inflammatory hypothesis revisited. Chest 2003; 124: 1187.Google Scholar

Klingsberg, RC, Mutsaers, SE, Lasky, JA. Current clinical trials for the treatment of idiopathic pulmonary fibrosis. Respirology 2010; 15: 19.CrossRefGoogle ScholarPubMed

Kottmann, RM, Hogan, CM, Phipps, RP, et al. Determinants of initiation and progression of idiopathic pulmonary fibrosis. Respirology 2009; 14: 917.CrossRefGoogle ScholarPubMed

Lin, C, Borensztajn, K, Spek, CA. Targeting coagulation factor receptors – protease-activated receptors in idiopathic pulmonary fibrosis. J Thromb Haemost 2017; 15: 597.Google Scholar

Lynch, DA, Godwin, JD, Safrin, S, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005; 172: 488.CrossRefGoogle ScholarPubMed

Marinelli, WA. Idiopathic pulmonary fibrosis: progress and challenge. Chest 1995; 108: 297.Google Scholar

Mason, DP, Brizzio, ME, Alster, JM, et al. Lung transplantation for idiopathic pulmonary fibrosis. Ann Thorac Surg 2007; 84: 1121.Google Scholar

Michaelson, JE, Aguayo, SM, Roman, J. Idiopathic pulmonary fibrosis. Chest 2000; 118: 788.Google Scholar

Prasad, J, Holland, AE, Glaspole, I, et al. Idiopathic pulmonary fibrosis: an Australian perspective. Intern Med J 2016; 46: 663.Google Scholar

Raghu, G, Collard, HR, Egan, JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788.Google Scholar

Riches, DWH, Worthen, GS, eds. Mechanisms of pulmonary fibrosis. Chest 2001; 120: suppl. 1.CrossRefGoogle Scholar

Schmidt, SL, Sundaram, B, Flaherty, KR. Diagnosing fibrotic lung disease: when is high-resolution computed tomography sufficient to make a diagnosis of idiopathic pulmonary fibrosis? Respirology 2009; 14: 934.CrossRefGoogle ScholarPubMed

Swaminathan, AC, Todd, JL. That was then, this is now: a fresh look at idiopathic pulmonary fibrosis biomarkers in the antifibrotic era. Chest 2020; 158: 1321.Google Scholar

Swigris, JJ, Kuschner, WG, Kelsey, JL, et al. Idiopathic pulmonary fibrosis. Chest 2005; 127: 275.Google Scholar

Turner-Warwick, M, Burrows, B, Johnson, A. Cryptogenic fibrosing alveolitis. Thorax 1980; 35: 171.CrossRefGoogle ScholarPubMed

Various. Controversies in the diagnosis and management of idiopathic pulmonary fibrosis. Chest 2005; 128 (suppl.): 513S.Google Scholar

Ziesche, R, Hofbauer, E, Wittmann, K, et al. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999; 341: 1264.CrossRefGoogle ScholarPubMed

Lawley, TJ, Bielory, L, Gascon, P, et al. A prospective clinical and immunologic analysis of patients with serum sickness. N Engl J Med 1984; 311: 1407.Google Scholar

Schifferli, JA, Ng, YC, Peters, DK. The role of complement and its receptors in the elimination of immune complexes. N Engl J Med 1986; 315: 488.Google Scholar

Wiggins, RC, Cochrane, CG. Immune-complex-mediated biologic effects. N Engl J Med 1981; 304: 518.Google Scholar

Choi, PY, Merriman, E, Bennett, A, et al. Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand. Med J Aust 2022; 216: 43.Google Scholar

Chong, BH. Primary immune thrombocytopenia: understanding pathogenesis is the key to better treatments. J Thromb Haemost 2009; 7: 319.Google Scholar

Cines, DB, Blanchette, VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 995.Google Scholar

Ferrara, JLM. The febrile platelet transfusion reaction: a cytokine shower. Transfusion 1995; 35: 89.Google Scholar

George, JN. Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost 2006; 4: 1664.Google Scholar

Kuter, DJ, Bussel, JB, Lyons, RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura. Lancet 2008; 371: 395.CrossRefGoogle ScholarPubMed

Lakshmanan, S, Cuker, A. Contemporary management of primary immune thrombocytopenia in adults. J Thromb Haemost 2012; 10: 1988.Google Scholar

Nugent, D, McMillan, R, Nichol, JL, et al. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol 2009; 146: 585.Google Scholar

Provan, D, Arnold, DM, Russell, JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019; 3: 3780.Google Scholar

Sivapathasingam, V, Harvey, MP, Wilson, RB. Helicobacter pylori eradication: a novel therapeutic option in chronic immune thrombocytopenic purpura. Med J Aust 2008; 189: 367.Google Scholar

Buckley, RH, Schiff, RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 1991; 325: 110.Google Scholar

Gupta, S, Pattaniak, D, Krishnaswamy, G. Common variable immune deficiency and associated complications. Chest 2019; 156: 579.Google Scholar

Sneller, MC, Strober, W, Eisenstein, E, et al. NIH conference: new insights into common variable immunodeficiency. Ann Intern Med 1993; 118: 720.Google Scholar

Sullivan, KE, Jyonoudi, S. Deficiencies of innate and adaptive immunity. In: Scientific American Medicine. Allergy & Immunology. Hamilton: Dekker Medicine. 2020.Google Scholar

Van de Meer, JWM, Kullberg, BJ. Defects in host-defense mechanisms. In: Rubin, RH, Young, LS, eds. Clinical Approach to Infections in the Compromised Host. 4th edition. New York: Plenum. 2002.Google Scholar

Yu, Z, Lennon, VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 1999; 340: 227.Google Scholar

Anderson, KC, Weinstein, HJ. Transfusion-associated graft-versus-host disease. N Engl J Med 1990; 323: 315.Google Scholar

Austen, KF, Burakoff, SJ, Rosen, FS, et al., eds. Therapeutic Immunology. 2nd edition. Cambridge: Blackwell. 2001.Google Scholar

Ballow, M, Nelson, R. Immunopharmacology: immunomodulation and immunotherapy. JAMA 1997; 278: 2008.CrossRefGoogle ScholarPubMed

Barnes, PJ, Karin, M. Nuclear factor-κβ – a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066.Google Scholar

Chrousos, GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351.Google Scholar

Clark, EA, Ledbetter, JA. How B and T cells talk to each other. Nature 1994; 367: 425.CrossRefGoogle Scholar

Cohen, JJ. Apoptosis. Immunol Today 1993; 14: 126.CrossRefGoogle ScholarPubMed

Couriel, D, Weinstein, R. Complications of therapeutic plasma exchange: a recent assessment. J Clin Apheresis 1994; 9: 1.CrossRefGoogle ScholarPubMed

Davies, PJ, Martin, SJ, Burton, DR, et al. Roitt’s Essential Immunology. 13th edition. Hoboken: Wiley 2018.Google Scholar

Dwyer, JM. Manipulating the immune system with immune globulin. N Engl J Med 1992; 326: 107.Google ScholarPubMed

Engelhard, VH. How cells process antigens. Sci Am 1994; 271(2): 54.Google Scholar

Faist, E, Wichmann, M, Kim, C. Immunosuppression and immunomodulation in surgical patients. Curr Opin Crit Care 1997; 3: 293.Google Scholar

Fox, DA, ed. Allergy & Immunology. Scientific American Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar

Guillet, J-G, Lai, M-Z, Briner, TJ, et al. Immunological self, nonself discrimination. Science 1987; 235: 865.Google Scholar

Lundy, SK, Gizinski, A, Fox, DA. Introduction to clinical immunology: overview of immune response, autoimmune conditions, and immunosuppressive therapeutics for rheumatic diseases. In: Scientific American Medicine. Allergy & Immunology. Hamilton: Dekker Medicine. 2020.Google Scholar

Nossal, GJV. Current concepts: immunology: the basic components of the immune system. N Engl J Med 1987; 316: 1320.Google Scholar

Nossal, GJV. Immunologic tolerance: collaboration between antigen and lymphokines. Science 1989; 245: 147.Google Scholar

Nossal, GJV. Life, death and the immune system. Sci Am 1993; 269(3): 20.CrossRefGoogle ScholarPubMed

Nossal, GJV. Negative selection of lymphocytes. Cell 1994; 76: 229.Google Scholar

Pardoll, DM. Tumour antigens: a new look for the 1990s. Nature 1994; 369: 357.Google Scholar

Parker, CW. Allergic reactions in man. Pharmacol Rev 1982; 34: 85.Google Scholar

Paul, WE. Infectious diseases and the immune system. Sci Am 1993; 269(3): 57.Google Scholar

Reichlin, S. Neuroendocrine-immune interactions. N Engl J Med 1993; 329: 1246.Google Scholar

Reimann, PM, Mason, PD. Plasmapheresis: technique and complications. Intens Care Med 1990; 16: 3.Google Scholar

Roberts, NJ. Impact of temperature elevation on immunologic defenses. Rev Infect Dis 1991; 13: 462.Google Scholar

Shortman, K, Scollay, R. Death in the thymus. Nature 1994; 372: 44.Google Scholar

Smith, RM, Giannoudis, PV. Trauma and the immune response. J R Soc Med 1998; 91: 417.Google Scholar

Van de Meer, JWM, Kullberg, BJ. Defects in host-defense mechanisms. In: Rubin, RH, Young, LS, eds. Clinical Approach to Infections in the Compromised Host. 4th edition. New York: Plenum. 2002.Google Scholar

Von Boehmer, H. Positive selection of lymphocytes. Cell 1994; 76: 219.Google Scholar

Yu, Z, Lennon, VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 1999; 340: 227.Google Scholar

Zanetti, G, Calandra, T. Intravenous immunoglobulins and granulocyte colony-stimulating factor for the management of infection in intensive care units. Curr Opin Crit Care 1997; 3: 342.Google Scholar

Zweiman, B, Levinson, AI. Immunologic aspects of neurological and neuromuscular diseases. JAMA 1992; 268: 2918.Google Scholar

Bearn, AG, Miller, ED. Archibald Garrod and the development of the concept of inborn errors of metabolism in the newborn period. Bull Hist Med 1979; 53: 315.Google Scholar

Chopra, SS, Berry, GT. Metabolic disorders: inborn errors of amino acid, ammonia, organic acid, and fatty acid metabolism. In: Scientific American Medicine. Endocrinology & Metabolism. Hamilton: Dekker Medicine. 2020.Google Scholar

Wappner, RS. Biochemical diagnosis of genetic diseases. Pediatr Ann 1993; 22: 282.Google Scholar

Wenger, DA, Copploa, S, Liu, SL. Insights into the diagnosis and treatment of lysosomal storage diseases. Arch Neurol 2003; 60: 322.Google Scholar

Azoulay, E, ed. Severe infections in the critically ill. Intens Care Med 2020; 46: no. 2.Google Scholar

Barrett-Connor, E. Anemia and infection. Am J Med 1972; 52: 242.Google Scholar

Bennett, JE, Dolin, R, Blaser, MJ, eds. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 9th edition. New York: Elsevier. 2019.Google Scholar

Bion, JF, Brun-Buisson, C, eds. Infection and critical illness: genetic and environmental aspects of susceptibility and resistance. Intens Care Med 2000; 26; suppl. 1.Google Scholar

Bohnsack, JF, Brown, EJ. The role of the spleen in resistance to infection. Annu Rev Med 1986; 37: 49.Google Scholar

Brigden, ML, Pattullo, AL. Prevention and management of overwhelming postsplenectomy infection – an update. Crit Care Med 1999; 27: 836.Google Scholar

Cassell, GH, Cole, BC. Mycoplasmas as agents of human disease. N Engl J Med 1981; 304: 80.Google Scholar

Cohen, S, Tyrrell, DA, Smith, AP. Psychological stress and susceptibility to the common cold. N Engl J Med 1991; 325: 606.Google Scholar

Cunha, BA, ed. Infectious Diseases in Critical Care Medicine. 3rd edition. Boca Baton: CRC Press. 2009.Google Scholar

Durand, MI, Calserwood, SB, Weber, MD, et al. Acute bacterial meningitis in adults. N Engl J Med 1993; 328: 21.Google Scholar

Fisman, DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000; 6: 6.Google Scholar

Gilbert, GL. Infections in pregnant women. Med J Aust 2002; 176: 229.Google Scholar

Gorbach, SL, Bartlett, JG, Blacklow, NR, eds. Infectious Diseases. 3rd edition. Philadelphia: WB Saunders. 2004.Google Scholar

Howard, CR. Viral hemorrhagic fevers: properties and prospects for treatment and prevention. Antiviral Res 1984; 4: 169.Google Scholar

Hughes, AJ, Biggs, BA. Parasitic worms of the central nervous system. Intern Med J 2002; 32: 541.Google Scholar

Keusch, GT, Barza, MJ, Bennish, ML, et al., eds. Year Book of Infectious Diseases 1998. St Louis: Mosby-Year Book. 1998.Google Scholar

Manocha, S, Walley, KR, Russell, JA. Severe acute respiratory distress syndrome (SARS): a critical care perspective. Crit Care Med 2003; 31: 2684.CrossRefGoogle ScholarPubMed

Maslin, F-X. Global aspects of emerging and potential zoonoses: a WHO perspective. Emerg Infect Dis 1997; 3: 2.Google Scholar

Paul, WE. Infectious diseases and the immune system. Sci Am 1993; 269(3): 57.Google Scholar

Peeling, RW, Brunham, RC. Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 1996; 2: 4.Google Scholar

Pinder, M, Bellomo, R, Lipman, J. Pharmacological principles of antibiotic prescription in the critically ill. Anaesth Intens Care 2002; 30: 134.Google Scholar

Rahall, JJ. Antibiotic combinations: the clinical relevance of synergy and antagonism. Medicine 1978; 57: 179.Google Scholar

Shafazand, S, Weinacker, AB. Blood cultures in the critical care unit: improving utilization and yield. Chest 2002; 122: 1727.Google Scholar

Sigurdardottir, B, Bjornsson, OM, Jonsdottir, KE, et al. Acute bacterial meningitis in adults. Arch Intern Med 1997; 157: 425.Google Scholar

Spach, D, Liles, W, Campbell, G, et al. Tick-borne diseases in the United States. N Engl J Med 1993; 329: 936.Google Scholar

Sprung, CL, Cohen, R, Adini, B, eds. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster. Summary report of the European Society of Intensive Care Medicine’s Task Force for intensive care unit triage during an influenza epidemic or mass disaster. Intens Care Med 2010; 36 (suppl. 1): S1.Google Scholar

Tomkins, L. The use of molecular methods in the diagnosis of infectious diseases. N Engl J Med 1992; 327: 1290.Google Scholar

Various. Infectious Diseases. In: Scientific American Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar

Whitley, RJ. Viral encephalitis. N Engl J Med 1990; 323: 242.Google Scholar

Zanetti, G, Calandra, T. Intravenous immunoglobulins and granulocyte colony-stimulating factor for the management of infection in intensive care units. Curr Opin Crit Care 1997; 3: 342.Google Scholar

Zumla, A, James, DG. Granulomatous infections: etiology and classification. Clin Infect Dis 1996; 23: 146.Google Scholar

Black, H, Mendoza, M, Murin, S. Thoracic manifestations of inflammatory bowel disease. Chest 2007; 131: 524.Google Scholar

Bongartz, T, Sutton, AJ, Sweeting, MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006; 295: 2275.Google Scholar

Carter, MJ, Lobo, AJ, Travis, SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 (suppl. 5): VI.Google Scholar

Colombel, JF, Loftus, EV, Tremaine, WJ, et al. The safety profile of infliximab in patients with Crohn’s disease. Gastroenterology 2004; 126: 19.Google Scholar

Davis, WC, Kuenstner, JT, Singh, SV. Resolution of Crohn’s (Johne’s) disease with antibiotics: what are the next steps?. Expert Rev Gastroenterol Hepatol 2017; 11: 393.Google Scholar

Fehily, SR, Basnayake, C, Wright, EK, et al. The gut microbiota and gut disease. Intern Med J 2021; 51: 1594.Google Scholar

Gibson, PR, Anderson, RP. Inflammatory bowel disease. Med J Aust 1998; 169: 387.Google Scholar

Greenberg, GR. Nutritional support in inflammatory bowel disease: current status and future directions. Scand J Gastroenterol 1992; 192 (suppl.): 117.Google Scholar

Greenstein, RJ. Is Crohn’s disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne’s disease. Lancet Infect Dis 2004; 4: 507.Google Scholar

Grimpen, F, Pavli, P. Advances in the management of inflammatory bowel disease. Intern Med J 2010; 40: 258.Google Scholar

Kornbluth, A, George, J, Sachar, DB. Immunosuppressive drugs in Crohn’s disease. Gastroenterologist 1994; 2: 239.Google ScholarPubMed

MacDermott, RP, Stenson, WF. Inflammatory Bowel Disease. New York: Elsevier. 1992.Google Scholar

McNees, AL, Markesich, D, Zayyani, NR, et al. Mycobacterium paratuberculosis as a cause of Crohn’s disease. Expert Rev Gastroenterol Hepatol 2015; 9: 1523.Google Scholar

Ng, SC, Shi, HY, Hamidi, N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2017; 390: 2769.Google Scholar

Podolsky, DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417.Google Scholar

Present, DH, Rutgeerts, P, Targan, S, et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 1999; 340: 1398.Google Scholar

Rachmilewitz, D. New forms of treatment for inflammatory bowel disease. Gut 1992; 33: 1301.Google Scholar

Sands, BE. Biologic therapy for inflammatory bowel disease. Inflamm Bowel Dis 1997; 3: 95.Google Scholar

Sands, BE, Anderson, FH, Bernstein, CN, et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. New Engl J Med 2004; 350: 876.Google Scholar

Shouval, DS. Evaluation and treatment of monogenic forms of inflammatory bowel diseases. In: Scientific American Medicine. Gastroenterology. Hamilton: Dekker Medicine. 2020.Google Scholar

Schreiber, S, Hampe, J. Genomics and inflammatory bowel disease. Curr Opin Gastroenterol 1999; 16: 297.Google Scholar

Selby, WS. Current issues in Crohn’s disease. Med J Aust 2003; 178: 532.Google Scholar

Thompson, NP, Montgomery, SM, Pounder, RE, et al. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995; 345: 1071.Google Scholar

ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361: 1925.Google Scholar

Arabi, Y, Gomersall, CD, Ahmed, QA, et al. The critically ill avian influenza A (H5N1) patient. Crit Care Med 2007; 35: 1397.Google Scholar

Beigel, JH. Influenza. Crit Care Med 2008; 36: 2660.Google Scholar

Beigel, JH, Farrar, J, Han, AM, et al. Avian influenza A (H5N1) infection in humans. New Engl J Med 2005; 353: 1374.Google Scholar

Bishop, JF, Murnane, MP, Owen, R. Australia’s winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med 2009; 361: 2591.Google Scholar

Dawood, FS, Jain, S, Finelli, L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360: 2605.Google Scholar

Dwyer, DE, Emery, S, McKinnon, M. Preparing for an influenza pandemic. Med J Aust 2006; 185 (suppl.): S25.Google Scholar

Gruber, PC, Gomersall, CD, Joynt, GM. Avian influenza (H5N1): implications for intensive care. Intens Care Med 2006; 32: 823.Google Scholar

Harrigan, PWJ, Webb, SAR, Seppelt, IM, et al. The practical experience of managing the H1N1 2009 influenza pandemic in Australian and New Zealand intensive care units. Crit Care Resusc 2010; 12: 121.Google Scholar

Loh, L-C, Hui, DS-C, Beasley, R, eds. Avian influenza: from basic biology to endemic planning. Respirology 2008; 13 (suppl.): S1.Google Scholar

Macfarlane, JT, Lim, WS. Bird flu and pandemic flu. BMJ 2005; 331: 975.CrossRefGoogle ScholarPubMed

Mitchell, MD, Mikkelsen, ME, Umscheid, CA, et al. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med 2010; 38: 1398.Google Scholar

Smith, GJ, Vijaykrishna, D, Bahl, J, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009; 459: 1122.Google Scholar

Sprung, CL, Cohen, R, Adini, B, eds. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster. Summary report of the European Society of Intensive Care Medicine’s Task Force for intensive care unit triage during an influenza epidemic or mass disaster. Intens Care Med 2010; 36 (suppl. 1): S1.Google Scholar

Torres, A, Martin-Loeches, I, Sligl, W. et al. Severe flu management: a point of view. Intens Care Med 2020; 46: 153.Google Scholar

Wong, SSY, Yuen, K-y. Avian influenza virus infections in humans. Chest 2006; 129: 156.Google Scholar

Yang, Y, Sugimoto, JD, Halloran, ME, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009; 326: 729.Google Scholar

Baud, FJ, Barriot, P, Toffis, V, et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med 1991; 325: 1761.Google Scholar

Crapo, RO. Smoke-inhalation injuries. JAMA 1981; 246: 1694.Google Scholar

Dancey, DR, Hayes, J, Gomez, M, et al. ARDS in patients with thermal injury. Intens Care Med 1999; 25: 1231.Google Scholar

de la Cal, MA, Cerda, E, Garcia-Hierro, P, et al. Pneumonia in patients with severe burns. Chest 2001; 119: 1160.Google Scholar

Dennekamp, M, Abramson, MJ. The effects of bushfire smoke on respiratory health. Respirology 2011; 16: 198.Google Scholar

Dietch, E. The management of burns. N Engl J Med 1990; 323: 1249.Google Scholar

Dyer, RF, Esch, VH. Polyvinyl chloride toxicity in fires: hydrogen chloride toxicity in firefighters. JAMA 1976; 235: 393.Google Scholar

Fogarty, PW, George, PJM, Solomon, M, et al. Long term effects of smoke inhalation in survivors of the King’s Cross underground station fire. Thorax 1991; 46: 914.Google Scholar

Gueugniaud, P-Y, Carsin, H, Bertin-Maghit, M, et al. Current advances in the initial management of major thermal burns. Intens Care Med 2000; 26: 848.Google Scholar

Haponik, E, Munster, A, eds. Respiratory Injury: Smoke Inhalation and Burns. New York: McGraw-Hill. 1990.Google Scholar

Hettiaratchy, S, Dziewulski, P. ABC of burns. BMJ 2004; 328: 1366 et seq.Google Scholar

Holley, AD, Reade, MC, Lipman, J, et al. There is no fire without smoke! Pathophysiology and treatment of inhalational injury in burns: a narrative review. Anaesth Intens Care 2020; 48: 114.Google Scholar

Large, AA, Owens, GR, Hoffman, LA. The short-term effects of smoke exposure on the pulmonary function of firefighters. Chest 1990; 97: 806.Google Scholar

Mlcak, RP, Suman, OE, Herndon, DN. Respiratory management of inhalation injury. Burns 2007; 33: 2.Google Scholar

Park, GY, Park, JW, Jeong, DH, et al. Prolonged airway and systemic inflammatory reactions after smoke inhalation. Chest 2003; 123: 475.Google Scholar

Ryan, CM, Schoenfeld, DA, Thorpe, WP, et al. Objective estimates of the probability of death from burn injuries. N Engl J Med 1998; 338: 362.Google Scholar

Schulz, JT, Ryan, CM. The frustrating problem of smoke inhalation injury. Crit Care Med 2000; 28: 1677.Google Scholar

Sheridan, R. Specific therapies for inhalation injury. Crit Care Med 2002; 30: 718.Google Scholar

Walker, PF, Buehner, MF, Wood, LA, et al. Diagnosis and management of inhalation injury: an updated review. Crit Care 2015; 19: 351.Google Scholar

Baughman, RP, Dent, M. Role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med 2001; 22: 331.Google Scholar

Chu, SC, Horiba, K, Usuki, J, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999; 115: 1041.Google Scholar

Coultas, DB, Zumwalt, RE, Black, WC, et al. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967.Google Scholar

Crystal, RG, Bitterman, PB, Rennard, SI, et al. Interstitial lung diseases of unknown cause. N Engl J Med 1984; 310: 154 & 235.Google Scholar

Kitaichi, M, Nishimura, K, Itoh, H, et al. Pulmonary lymphangioleiomyomatosis. Am J Respir Crit Care Med 1995; 151: 527.Google Scholar

McCormack, FX. Lymphangioleiomyomatosis: a clinical update. Chest 2008; 133: 507.Google Scholar

Moss, J, ed. LAM (lymphangioleiomyomatosis) and Other Diseases Characterized by Smooth Muscle Proliferation. New York: Marcel Dekker. 1999.Google Scholar

Prakash, UB, Barham, SS, Rosenow, EC, et al. Pulmonary alveolar microlithiasis. Mayo Clin Proc 1983; 58: 290.Google Scholar

Reynolds, HY. Diagnostic and management strategies for diffuse interstitial lung disease. Chest 1998; 113: 192.Google Scholar

Skolnik, K, Ryerson, CJ. Unclassifiable interstitial lung disease: a review. Respirology 2016; 21: 51.Google Scholar

Taylor, JR, Ryu, J, Colby, TV, et al. Lymphangioleiomyomatosis. N Engl J Med 1990; 323: 1254.Google Scholar

Vij, R, Strek, ME. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease Chest 2013: 143: 814.Google Scholar

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, June 2001. Am J Respir Crit Care Med 2002; 165: 277.Google Scholar

Boehler, A, Kesten, S, Weder, W, et al. Bronchiolitis obliterans after lung transplantation: a review. Chest 1998; 114: 1411.Google Scholar

Cha, SI, Fessler, MB, Cool, CD, et al. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J 2006; 28: 364.Google Scholar

Cordier, JF. Cryptogenic organising pneumonia. Eur Respir J 2006; 28: 422.Google Scholar

Epler, GR, Colby, TV, McLoud, TC, et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 312: 152.Google Scholar

Fischer, A, West, SG, Swigris, JJ, et al. Connective tissue disease-associated interstitial lung disease. Chest 2010; 138: 251.Google Scholar

Frankel, SK, Cool, CD, Lynch, DA, et al. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004; 126: 2007.Google Scholar

Hamman, L, Rich, AR. Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climatol Assoc 1935; 51: 154.Google Scholar

Kinder, BW, Collard, HR, Koth, L, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease. Am J Respir Crit Care Med 2007; 176: 691.Google Scholar

Ryu, JH, Myers, JL, Capizzi, SA, et al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 2005; 127: 178.Google Scholar

Travis, WD, Costabel, U, Hansell, DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2013; 188: 733.Google Scholar

Vourlekis, JS. Acute interstitial pneumonia. Clin Chest Med 2004; 25: 739.Google Scholar

Kirkpatrick, AW, Roberts, DJ, De Waele, J, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intens Care Med 2013; 39: 1190.Google Scholar

Maluso, P, Olson, J, Sarani, B. Abdominal compartment hypertension and abdominal compartment syndrome. Crit Care Clin 2016; 32: 213.Google Scholar

Rogers, WK, Garcia, L. Intraabdominal hypertension, abdominal compartment syndrome, and the open abdomen. Chest 2018; 153: 238.Google Scholar

Bothwell, TH, Charlton, RW, Cook, JD, et al. Iron Metabolism in Man. Oxford: Blackwell. 1979.Google Scholar

Conrad, ME, Umbreit, JN, Moore, EG. Iron absorption and cellular uptake of iron. Adv Exp Med Biol 1994; 356: 69.Google Scholar

Editorial. Serum-ferritin. Lancet 1979; 1: 533.Google Scholar

Finch, CA. Erythropoiesis, erythropoietin, and iron. Blood 1982; 60: 1241.Google Scholar

Finch, CA. The detection of iron overload. N Engl J Med 1982; 307: 1702.Google Scholar

Finch, CA, Huebers, H. Perspectives in iron metabolism. N Engl J Med 1992; 306: 1520.Google Scholar

Ganz, T, Nemeth, E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol 2015; 15: 500.Google Scholar

Hershko, C, Peto, TEA, Weatherall, DJ. Iron and infection. BMJ 1988; 296: 660.Google Scholar

Huebers, HA, Finch, CA. The physiology of transferrin and transferrin receptors. Physiol Rev 1987; 67: 520.Google Scholar

Kuhn, LC. Molecular regulation of iron proteins. Baillieres Clin Haematol 1994; 7: 763.Google Scholar

Means, RT. Red blood cell function and disorders of iron metabolism. In: Scientific American Medicine. Hematology. Hamilton: Dekker Medicine. 2020.Google Scholar

Mills, KC, Curry, SC. Acute iron poisoning. Emerg Clin North Am 1994; 12: 397.Google Scholar

Pieracci, FM, Barie, PS. Diagnosis and management of iron-related anemias in critical illness. Crit Care Med 2006; 34: 1898.Google Scholar

Sayers, MH, English, G, Finch, C. Capacity of the store-regulator in maintaining iron balance. Am J Hematol 1994; 47: 194.Google Scholar

Cook, JD, Skikne, BS. Iron deficiency: definition and diagnosis. J Intern Med 1989; 226: 349.Google Scholar

Hershko, C, Peto, TEA, Weatherall, DJ. Iron and infection. BMJ 1988; 296: 660.Google Scholar

Lopez, A, Cacoub, P, Macdougall, IC, et al. Iron deficiency anaemia. Lancet 2016; 387: 907.Google Scholar

Low, MSY, Grigoriadis G. Iron deficiency and new insights into therapy. Med J Aust 2017; 207: 81.Google Scholar

Pasricha, SR, Flecknoe-Brown, SC, Allen, KJ, et al. Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust 2010; 193: 525.Google Scholar

Le Quesne, LP, Nabarro, JDN, Kurtz, A, et al. The management of insulin tumours of the pancreas. Br J Surg 1979; 66: 31.Google Scholar